Cue Health logo

Cue Health Funding & Investors

Cue is a revolutionary device for tracking health information at the molecular level. For the first time, consumers can track 5 key health and lifestyle indicators: inflammation, vitamin D, fertility, influenza, and testosterone in just minutes, at home. Cue sends the data via Bluetooth 4.0 to the user's smartphone, where the free Cue app reveals the interplay of activity, food, and sleep shaping the user at a molecular level.

cuehealth.com

Total Amount Raised: $904,318,336

Cue Health Funding Rounds

  • Series Unknown

    $235,000,000

    Series Unknown Investors

    Johnson & Johnson Innovation – JJDC
    Koch Strategic Platforms
    Decheng Capital
    ACME Capital
    Perceptive Advisors
    CAVU Consumer Partners
    MSD Capital
  • Grant

    $481,000,000

    Grant Investors

    U.S. Department of Health and Human Services (HHS)
    Department of Defense
  • Series Unknown

    $235,000,000

    Series Unknown Investors

    Johnson & Johnson Innovation – JJDC
    Koch Strategic Platforms
    Decheng Capital
    ACME Capital
    Perceptive Advisors
    CAVU Consumer Partners
    MSD Capital
  • Grant

    $481,000,000

    Grant Investors

    U.S. Department of Health and Human Services (HHS)
    Department of Defense
  • Series C

    $102,603,339

    Series C Investors

    Johnson & Johnson Innovation – JJDC
    Tarsadia Investments
    Decheng Capital
    ACME Capital
    Foresite Capital
    Madrone Capital Partners
  • Series C

    $102,603,339

    Series C Investors

    Johnson & Johnson Innovation – JJDC
    Tarsadia Investments
    Decheng Capital
    ACME Capital
    Foresite Capital
    Madrone Capital Partners
  • Grant

    $13,000,000

    Grant Investors

    Biomedical Advanced Research and Development Authority
  • Series B

    $45,000,000

    Series B Investors

    HT Capital
    Tarsadia Investments
    Troy Capital Partners
    Synergy Ventures
    Babel Ventures
    ACME Capital
    Dentsu Ventures
    Johnson & Johnson
    Section 32
    Pritzker Group Venture Capital
    Cove Investments
    Rohan Oza
  • Series B

    $15,500,000

    Series B Investors

    Shervin Pishevar
    MaC Venture Capital
    ACME Capital
    Flat World Partners
    Rohan Oza
  • Series A

    $7,500,000

    Series A Investors

    Shervin Pishevar
    Immortalana
    ACME Capital
    Leonardo DiCaprio
    Marc Benioff
    Jim Messina
  • Series A

    $4,000,000

    Series A Investors

    David Rusenko
    Sequoia Capital
    Keith Rabois
  • Seed

    $700,000

    Seed Investors

    Christina Brodbeck
    Lerer Hippeau
    Founder Collective
    Paul Buchheit
    Thrive Capital
    SVA
    Bret Taylor
    SK Telecom Ventures
    Joshua Kushner
  • Grant

    $13,000,000

    Grant Investors

    Biomedical Advanced Research and Development Authority
  • Series B

    $45,000,000

    Series B Investors

    HT Capital
    Tarsadia Investments
    Troy Capital Partners
    Synergy Ventures
    Babel Ventures
    ACME Capital
    Dentsu Ventures
    Johnson & Johnson
    Section 32
    Pritzker Group Venture Capital
    Cove Investments
    Rohan Oza
  • Series B

    $15,500,000

    Series B Investors

    Shervin Pishevar
    MaC Venture Capital
    ACME Capital
    Flat World Partners
    Rohan Oza
  • Series A

    $7,500,000

    Series A Investors

    Shervin Pishevar
    Immortalana
    ACME Capital
    Leonardo DiCaprio
    Marc Benioff
    Jim Messina
  • Series A

    $4,000,000

    Series A Investors

    David Rusenko
    Sequoia Capital
    Keith Rabois
  • Seed

    $700,000

    Seed Investors

    Christina Brodbeck
    Lerer Hippeau
    Founder Collective
    Paul Buchheit
    Thrive Capital
    SVA
    Bret Taylor
    SK Telecom Ventures
    Joshua Kushner
  • Seed

    $15,000

    Seed Investors

    Y Combinator
  • Seed

    $15,000

    Seed Investors

    Y Combinator
Funding info provided by Diffbot.